+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Neurodegenerative Disease Market: By Drug Class & by Indications & Geography - Forecast 2016-2021

  • ID: 3973955
  • Report
  • 142 pages
  • IndustryARC
1 of 2
Neurodegenerative disease or neurodegeneration is disease which is causes the progressive damage or wear and tear of the nerve cells. This disease causes loss of abilities like decision making and eventually memory loss. This diseases are debilitating and incurable conditions which results in progressive degeneration of neurons and lead to problems with mental functioning and movement. Major cause of neurodegeneration could be deposition of toxic protein substance in the brain or loss of functionality/improper functioning of mitochondria present in brain. Patients generally show mixture of symptoms for one or more neurodegenerative disease. The prevalence of these conditions is on a constant rise across the globe, yet there is a general lack of effective therapies to treat the same.

Geographically North America dominated global neurodegenerative disease market, due to advanced medical infrastructure and approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the peripheral intervention market size in for the year 2016-2021, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Neurodegenerative Disease market.

This report is segmented into three major drug type. Some of the major drug type covered in this report are as follows: NMDA, SSRIs, Dopamine Inhibitors
This report is segmented into three major indicators. Some of the major indicators covered in this report are as follows: Parkinson’s & Huntington disease, Amyotrophic Lateral Sclerosis, Alzheimer’s disease and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for Neurodegenerative Disease in each of the region.

This report identifies all the major companies operating in the global Neurodegenerative Disease market. Some of the major companies’ profiles in detail are as follows:

Merck Serono
Biogen Idec
TEVA Pharmaceuticals Industries
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Neurodegenerative Disease– Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Neurodegenerative Disease– Market Forces
4.1. Drivers
4.1.1. Rapidly ageing population with increasing risk of developing neurological disorders
4.2. Opportunities
4.2.1. Increasing awareness in the developing nations
4.3. Challenges
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Degree of Competition

5. Neurodegenerative Disease– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Neurodegenerative Disease Market, By Drug class
6.1. NMDA
6.2. SSRIs
6.3. Dopamine Inhibitors
6.4. Others

7. Neurodegenerative Disease Market, By Indications
7.1. Parkinson’s & Huntington disease
7.2. Amyotrophic Lateral Sclerosis
7.3. Alzheimer’s disease]Chemotherapy
7.4. Others

8. Neurodegenerative Disease Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Neurodegenerative Disease– Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Top 10 Companies)
10.1. Novartis
10.2. Pfizer
10.3. Merck Serono
10.4. Biogen Idec
10.5. TEVA Pharmaceuticals Industries
10.6. UCB
10.7. Boehringer Ingelheim
10.8. Sanofi S.A
10.9. GlaxoSmithKline
10.10. Neuro-Hitech, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 2